"Quantification of Steroid Receptors Gene Expression in Breast Cancer Patients: Possible Correlation with Serum Level of Adipocytokines"
written by Rana Jahanban Esfahlan, Nosratollah Zarghami, Μohammad Rahmati-Yamchi, Amir Monfaredan, Samira Valiyari, Ali Jahanban Esfahlan, Raziallah Jafari Jozani, Morteza Gojazadeh, Fereidoun Mamaghani, Majid Mobasseri,
published by Journal of Cancer Therapy, Vol.2 No.5, 2011
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Implications of resistin in type 2 diabetes mellitus and coronary artery disease: Impairing insulin function and inducing pro‐inflammatory cytokines
2019
[2] Hesa-A Improves Clinical Outcome of Oral Carcinoma by Affecting p53 Gene Expression in vivo
2015
[3] Hesa-A Down-Regulates erb/b2 Oncogene Expression and Improves Outcome of Oral Carcinoma in a Rat Model
2015
[4] Anti Tumoral Properties of Punica Granatum (Pomegranate) Peel Extract on Different Human Cancer Cells
2015
[5] Anti Proliferative Properties of Melissa officinalis in Different Human Cancer Cells
2015
[6] Anti-proliferative properties of Cornus mass fruit in different human cancer cells
2015
[7] Anti-Proliferative Effects of Hesa-A on Human Cancer Cells with Different Metastatic Potential
2015
[8] Anti Tumoral Properties of Punica Granatum (Pomegranate) Peel Extract on Different Human Cancer Cells.
Asian Pacific journal of cancer prevention: APJCP, 2015
[9] Anti Proliferative Properties of Melissa officinalis in Different Human Cancer Cells.
Asian Pacific journal of cancer prevention: APJCP, 2015
[10] Hesa-A Improves Clinical Outcome of Oral Carcinoma by Affecting p53 Gene Expression in vivo.
Asian Pacific journal of cancer prevention: APJCP, 2015
[11] Novel DOX-MTX nanoparticles improve oral SCC clinical outcome by down regulation of lymph dissemination factor VEGF-C expression in vivo: oral and IV …
2014
[12] Oral and IV Dosages of Doxorubicin-Methotrexate loaded-Nanoparticles Inhibit Progression of Oral Cancer by Down-Regulation of Matrix Methaloproteinase 2 …
2014
[13] New formulated “DOX-MTX-loaded nanoparticles” downregulate HER2 gene expression and improve the clinical outcome in OSCCs model in rat: the effect of …
2014
[14] DOXMTX-NPs augment p53 mRNA expression in OSCC model in rat: effects of IV and oral routes
2014
[15] Novel DOX-MTX Nanoparticles Improve Oral SCC Clinical Outcome by Down Regulation of Lymph Dissemination Factor VEGF-C Expression in vivo: Oral and IV Modalities
Asian Pacific journal …, 2014
[16] New formulated “DOX-MTX-loaded Nanoparticles” Down-regulate HER2 Gene Expression and Improve the Clinical Outcome in OSCCs Model in Rat: the Effect of IV and Oral Modalities
Asian Pacific Journal of Cancer Prevention, 2014
[17] DOX-MTX-NPs Augment p53 mRNA Expression in OSCC Model in Rat: Effects of IV and Oral Routes
Asian Pacific Journal of Cancer Prevention, 2014
[18] Oral and IV Dosages of Doxorubicin-Methotrexate loaded-Nanoparticles Inhibit Progression of Oral Cancer by Down-Regulation of Matrix Methaloproteinase 2 Expression in Vivo.
Asian Pacific journal of cancer prevention: APJCP, 2014
[19] New formulated “DOX-MTX-loaded nanoparticles” downregulate HER2 gene expression and improve the clinical outcome in OSCCs model in rat: the effect of …
2014
[20] Adiponectin can affect ER signaling in obese breast cancer patients
Journal of Cancer Therapy, 2012